1 Study Coverage 1.1 Non-invasive Neuromodulation Device Product Introduction 1.2 Global Non-invasive Neuromodulation Device Outlook 2017 VS 2022 VS 2028 1.2.1 Global Non-invasive Neuromodulation Device Sales in US$ Million for the Year 2017-2028 1.2.2 Global Non-invasive Neuromodulation Device Sales in Volume for the Year 2017-2028 1.3 United States Non-invasive Neuromodulation Device Outlook 2017 VS 2022 VS 2028 1.3.1 United States Non-invasive Neuromodulation Device Sales in US$ Million for the Year 2017-2028 1.3.2 United States Non-invasive Neuromodulation Device Sales in Volume for the Year 2017-2028 1.4 Non-invasive Neuromodulation Device Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Non-invasive Neuromodulation Device in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Non-invasive Neuromodulation Device Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Non-invasive Neuromodulation Device Market Dynamics 1.5.1 Non-invasive Neuromodulation Device Industry Trends 1.5.2 Non-invasive Neuromodulation Device Market Drivers 1.5.3 Non-invasive Neuromodulation Device Market Challenges 1.5.4 Non-invasive Neuromodulation Device Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Non-invasive Neuromodulation Device Market Segment by Type 2.1.1 Transcranial Direct Current Stimulation (tDCS) 2.1.2 Transcranial Alternating Current Stimulation (tACS) 2.1.3 Transcranial Pulsed Current Stimulation (tPCS) 2.1.4 Transcranial Random Noise Stimulation (tRNS) 2.1.5 Electroconvulsive therapy (ECT) 2.1.6 Others 2.2 Global Non-invasive Neuromodulation Device Market Size by Type 2.2.1 Global Non-invasive Neuromodulation Device Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Non-invasive Neuromodulation Device Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Non-invasive Neuromodulation Device Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Non-invasive Neuromodulation Device Market Size by Type 2.3.1 United States Non-invasive Neuromodulation Device Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Non-invasive Neuromodulation Device Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Non-invasive Neuromodulation Device Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Non-invasive Neuromodulation Device Market Segment by Application 3.1.1 Hospital 3.1.2 Clinic 3.1.3 Others 3.2 Global Non-invasive Neuromodulation Device Market Size by Application 3.2.1 Global Non-invasive Neuromodulation Device Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Non-invasive Neuromodulation Device Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Non-invasive Neuromodulation Device Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Non-invasive Neuromodulation Device Market Size by Application 3.3.1 United States Non-invasive Neuromodulation Device Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Non-invasive Neuromodulation Device Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Non-invasive Neuromodulation Device Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Non-invasive Neuromodulation Device Competitor Landscape by Company 4.1 Global Non-invasive Neuromodulation Device Market Size by Company 4.1.1 Top Global Non-invasive Neuromodulation Device Manufacturers Ranked by Revenue (2021) 4.1.2 Global Non-invasive Neuromodulation Device Revenue by Manufacturer (2017-2022) 4.1.3 Global Non-invasive Neuromodulation Device Sales by Manufacturer (2017-2022) 4.1.4 Global Non-invasive Neuromodulation Device Price by Manufacturer (2017-2022) 4.2 Global Non-invasive Neuromodulation Device Concentration Ratio (CR) 4.2.1 Non-invasive Neuromodulation Device Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Non-invasive Neuromodulation Device in 2021 4.2.3 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Non-invasive Neuromodulation Device Manufacturing Base Distribution, Product Type 4.3.1 Global Non-invasive Neuromodulation Device Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Non-invasive Neuromodulation Device Product Type 4.3.3 Date of International Manufacturers Enter into Non-invasive Neuromodulation Device Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Non-invasive Neuromodulation Device Market Size by Company 4.5.1 Top Non-invasive Neuromodulation Device Players in United States, Ranked by Revenue (2021) 4.5.2 United States Non-invasive Neuromodulation Device Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Non-invasive Neuromodulation Device Sales by Players (2020, 2021 & 2022) 5 Global Non-invasive Neuromodulation Device Market Size by Region 5.1 Global Non-invasive Neuromodulation Device Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Non-invasive Neuromodulation Device Market Size in Volume by Region (2017-2028) 5.2.1 Global Non-invasive Neuromodulation Device Sales in Volume by Region: 2017-2022 5.2.2 Global Non-invasive Neuromodulation Device Sales in Volume Forecast by Region (2023-2028) 5.3 Global Non-invasive Neuromodulation Device Market Size in Value by Region (2017-2028) 5.3.1 Global Non-invasive Neuromodulation Device Sales in Value by Region: 2017-2022 5.3.2 Global Non-invasive Neuromodulation Device Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Non-invasive Neuromodulation Device Market Size YoY Growth 2017-2028 6.1.2 North America Non-invasive Neuromodulation Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 United States 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Non-invasive Neuromodulation Device Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Non-invasive Neuromodulation Device Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Non-invasive Neuromodulation Device Market Size YoY Growth 2017-2028 6.3.2 Europe Non-invasive Neuromodulation Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Non-invasive Neuromodulation Device Market Size YoY Growth 2017-2028 6.4.2 Latin America Non-invasive Neuromodulation Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Non-invasive Neuromodulation Device Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Non-invasive Neuromodulation Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Neuroelectrics 7.1.1 Neuroelectrics Corporation Information 7.1.2 Neuroelectrics Description and Business Overview 7.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Neuroelectrics Non-invasive Neuromodulation Device Products Offered 7.1.5 Neuroelectrics Recent Development 7.2 Magstim 7.2.1 Magstim Corporation Information 7.2.2 Magstim Description and Business Overview 7.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Magstim Non-invasive Neuromodulation Device Products Offered 7.2.5 Magstim Recent Development 7.3 NeuroCare Group 7.3.1 NeuroCare Group Corporation Information 7.3.2 NeuroCare Group Description and Business Overview 7.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.3.4 NeuroCare Group Non-invasive Neuromodulation Device Products Offered 7.3.5 NeuroCare Group Recent Development 7.4 Soterix Medical 7.4.1 Soterix Medical Corporation Information 7.4.2 Soterix Medical Description and Business Overview 7.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Soterix Medical Non-invasive Neuromodulation Device Products Offered 7.4.5 Soterix Medical Recent Development 7.5 Newronika 7.5.1 Newronika Corporation Information 7.5.2 Newronika Description and Business Overview 7.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Newronika Non-invasive Neuromodulation Device Products Offered 7.5.5 Newronika Recent Development 7.6 Rogue Resolutions 7.6.1 Rogue Resolutions Corporation Information 7.6.2 Rogue Resolutions Description and Business Overview 7.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Products Offered 7.6.5 Rogue Resolutions Recent Development 7.7 Medtronic 7.7.1 Medtronic Corporation Information 7.7.2 Medtronic Description and Business Overview 7.7.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Medtronic Non-invasive Neuromodulation Device Products Offered 7.7.5 Medtronic Recent Development 7.8 Philips Healthcare 7.8.1 Philips Healthcare Corporation Information 7.8.2 Philips Healthcare Description and Business Overview 7.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Philips Healthcare Non-invasive Neuromodulation Device Products Offered 7.8.5 Philips Healthcare Recent Development 7.9 Shenzhen Yingchi Technology 7.9.1 Shenzhen Yingchi Technology Corporation Information 7.9.2 Shenzhen Yingchi Technology Description and Business Overview 7.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Products Offered 7.9.5 Shenzhen Yingchi Technology Recent Development 7.10 Shenzhen Hanix United 7.10.1 Shenzhen Hanix United Corporation Information 7.10.2 Shenzhen Hanix United Description and Business Overview 7.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Products Offered 7.10.5 Shenzhen Hanix United Recent Development 7.11 Shanghai Qiankang Medical Care Company 7.11.1 Shanghai Qiankang Medical Care Company Corporation Information 7.11.2 Shanghai Qiankang Medical Care Company Description and Business Overview 7.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Products Offered 7.11.5 Shanghai Qiankang Medical Care Company Recent Development 7.12 TCT Research 7.12.1 TCT Research Corporation Information 7.12.2 TCT Research Description and Business Overview 7.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.12.4 TCT Research Products Offered 7.12.5 TCT Research Recent Development 7.13 EB Neuro SpA 7.13.1 EB Neuro SpA Corporation Information 7.13.2 EB Neuro SpA Description and Business Overview 7.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2017-2022) 7.13.4 EB Neuro SpA Products Offered 7.13.5 EB Neuro SpA Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Non-invasive Neuromodulation Device Industry Chain Analysis 8.2 Non-invasive Neuromodulation Device Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Non-invasive Neuromodulation Device Distributors 8.3 Non-invasive Neuromodulation Device Production Mode & Process 8.4 Non-invasive Neuromodulation Device Sales and Marketing 8.4.1 Non-invasive Neuromodulation Device Sales Channels 8.4.2 Non-invasive Neuromodulation Device Distributors 8.5 Non-invasive Neuromodulation Device Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Non-invasive Neuromodulation Device CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Non-invasive Neuromodulation Device Market Trends Table 3. Non-invasive Neuromodulation Device Market Drivers Table 4. Non-invasive Neuromodulation Device Market Challenges Table 5. Non-invasive Neuromodulation Device Market Restraints Table 6. Global Non-invasive Neuromodulation Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Non-invasive Neuromodulation Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Non-invasive Neuromodulation Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Non-invasive Neuromodulation Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Non-invasive Neuromodulation Device Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Non-invasive Neuromodulation Device Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Non-invasive Neuromodulation Device Revenue Share by Manufacturer, 2017-2022 Table 13. Global Non-invasive Neuromodulation Device Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Non-invasive Neuromodulation Device Sales Share by Manufacturer, 2017-2022 Table 15. Global Non-invasive Neuromodulation Device Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Non-invasive Neuromodulation Device Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Non-invasive Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Neuromodulation Device as of 2021) Table 18. Top Players of Non-invasive Neuromodulation Device in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Non-invasive Neuromodulation Device Product Type Table 20. Date of International Manufacturers Enter into Non-invasive Neuromodulation Device Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Non-invasive Neuromodulation Device Players in United States Market, Ranking by Revenue (2021) Table 23. United States Non-invasive Neuromodulation Device Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Non-invasive Neuromodulation Device Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Non-invasive Neuromodulation Device Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Non-invasive Neuromodulation Device Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Non-invasive Neuromodulation Device Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Non-invasive Neuromodulation Device Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Non-invasive Neuromodulation Device Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Non-invasive Neuromodulation Device Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Non-invasive Neuromodulation Device Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Non-invasive Neuromodulation Device Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Non-invasive Neuromodulation Device Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Non-invasive Neuromodulation Device Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Non-invasive Neuromodulation Device Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Non-invasive Neuromodulation Device Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Non-invasive Neuromodulation Device Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Non-invasive Neuromodulation Device Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Neuroelectrics Corporation Information Table 43. Neuroelectrics Description and Business Overview Table 44. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Neuroelectrics Non-invasive Neuromodulation Device Product Table 46. Neuroelectrics Recent Development Table 47. Magstim Corporation Information Table 48. Magstim Description and Business Overview Table 49. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Magstim Product Table 51. Magstim Recent Development Table 52. NeuroCare Group Corporation Information Table 53. NeuroCare Group Description and Business Overview Table 54. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. NeuroCare Group Product Table 56. NeuroCare Group Recent Development Table 57. Soterix Medical Corporation Information Table 58. Soterix Medical Description and Business Overview Table 59. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Soterix Medical Product Table 61. Soterix Medical Recent Development Table 62. Newronika Corporation Information Table 63. Newronika Description and Business Overview Table 64. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. Newronika Product Table 66. Newronika Recent Development Table 67. Rogue Resolutions Corporation Information Table 68. Rogue Resolutions Description and Business Overview Table 69. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. Rogue Resolutions Product Table 71. Rogue Resolutions Recent Development Table 72. Medtronic Corporation Information Table 73. Medtronic Description and Business Overview Table 74. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. Medtronic Product Table 76. Medtronic Recent Development Table 77. Philips Healthcare Corporation Information Table 78. Philips Healthcare Description and Business Overview Table 79. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Philips Healthcare Product Table 81. Philips Healthcare Recent Development Table 82. Shenzhen Yingchi Technology Corporation Information Table 83. Shenzhen Yingchi Technology Description and Business Overview Table 84. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. Shenzhen Yingchi Technology Product Table 86. Shenzhen Yingchi Technology Recent Development Table 87. Shenzhen Hanix United Corporation Information Table 88. Shenzhen Hanix United Description and Business Overview Table 89. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. Shenzhen Hanix United Product Table 91. Shenzhen Hanix United Recent Development Table 92. Shanghai Qiankang Medical Care Company Corporation Information Table 93. Shanghai Qiankang Medical Care Company Description and Business Overview Table 94. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. Shanghai Qiankang Medical Care Company Product Table 96. Shanghai Qiankang Medical Care Company Recent Development Table 97. TCT Research Corporation Information Table 98. TCT Research Description and Business Overview Table 99. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. TCT Research Product Table 101. TCT Research Recent Development Table 102. EB Neuro SpA Corporation Information Table 103. EB Neuro SpA Description and Business Overview Table 104. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. EB Neuro SpA Product Table 106. EB Neuro SpA Recent Development Table 107. Key Raw Materials Lists Table 108. Raw Materials Key Suppliers Lists Table 109. Non-invasive Neuromodulation Device Customers List Table 110. Non-invasive Neuromodulation Device Distributors List Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Non-invasive Neuromodulation Device Product Picture Figure 2. Global Non-invasive Neuromodulation Device Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Non-invasive Neuromodulation Device Market Size 2017-2028 (US$ Million) Figure 4. Global Non-invasive Neuromodulation Device Sales 2017-2028 (K Units) Figure 5. United States Non-invasive Neuromodulation Device Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Non-invasive Neuromodulation Device Market Size 2017-2028 (US$ Million) Figure 7. United States Non-invasive Neuromodulation Device Sales 2017-2028 (K Units) Figure 8. United States Non-invasive Neuromodulation Device Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Non-invasive Neuromodulation Device Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Non-invasive Neuromodulation Device Report Years Considered Figure 11. Product Picture of Transcranial Direct Current Stimulation (tDCS) Figure 12. Product Picture of Transcranial Alternating Current Stimulation (tACS) Figure 13. Product Picture of Transcranial Pulsed Current Stimulation (tPCS) Figure 14. Product Picture of Transcranial Random Noise Stimulation (tRNS) Figure 15. Product Picture of Electroconvulsive therapy (ECT) Figure 16. Product Picture of Others Figure 17. Global Non-invasive Neuromodulation Device Market Share by Type in 2022 & 2028 Figure 18. Global Non-invasive Neuromodulation Device Sales in Value by Type (2017-2028) & (US$ Million) Figure 19. Global Non-invasive Neuromodulation Device Sales Market Share in Value by Type (2017-2028) Figure 20. Global Non-invasive Neuromodulation Device Sales by Type (2017-2028) & (K Units) Figure 21. Global Non-invasive Neuromodulation Device Sales Market Share in Volume by Type (2017-2028) Figure 22. Global Non-invasive Neuromodulation Device Price by Type (2017-2028) & (US$/Unit) Figure 23. United States Non-invasive Neuromodulation Device Market Share by Type in 2022 & 2028 Figure 24. United States Non-invasive Neuromodulation Device Sales in Value by Type (2017-2028) & (US$ Million) Figure 25. United States Non-invasive Neuromodulation Device Sales Market Share in Value by Type (2017-2028) Figure 26. United States Non-invasive Neuromodulation Device Sales by Type (2017-2028) & (K Units) Figure 27. United States Non-invasive Neuromodulation Device Sales Market Share in Volume by Type (2017-2028) Figure 28. United States Non-invasive Neuromodulation Device Price by Type (2017-2028) & (US$/Unit) Figure 29. Product Picture of Hospital Figure 30. Product Picture of Clinic Figure 31. Product Picture of Others Figure 32. Global Non-invasive Neuromodulation Device Market Share by Application in 2022 & 2028 Figure 33. Global Non-invasive Neuromodulation Device Sales in Value by Application (2017-2028) & (US$ Million) Figure 34. Global Non-invasive Neuromodulation Device Sales Market Share in Value by Application (2017-2028) Figure 35. Global Non-invasive Neuromodulation Device Sales by Application (2017-2028) & (K Units) Figure 36. Global Non-invasive Neuromodulation Device Sales Market Share in Volume by Application (2017-2028) Figure 37. Global Non-invasive Neuromodulation Device Price by Application (2017-2028) & (US$/Unit) Figure 38. United States Non-invasive Neuromodulation Device Market Share by Application in 2022 & 2028 Figure 39. United States Non-invasive Neuromodulation Device Sales in Value by Application (2017-2028) & (US$ Million) Figure 40. United States Non-invasive Neuromodulation Device Sales Market Share in Value by Application (2017-2028) Figure 41. United States Non-invasive Neuromodulation Device Sales by Application (2017-2028) & (K Units) Figure 42. United States Non-invasive Neuromodulation Device Sales Market Share in Volume by Application (2017-2028) Figure 43. United States Non-invasive Neuromodulation Device Price by Application (2017-2028) & (US$/Unit) Figure 44. North America Non-invasive Neuromodulation Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. North America Non-invasive Neuromodulation Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. United States Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. Canada Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Europe Non-invasive Neuromodulation Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 49. Europe Non-invasive Neuromodulation Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 50. Germany Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. France Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. U.K. Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Italy Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Russia Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Asia-Pacific Non-invasive Neuromodulation Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 56. Asia-Pacific Non-invasive Neuromodulation Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 57. China Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Japan Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. South Korea Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. India Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Australia Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. China Taiwan Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Indonesia Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Thailand Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Malaysia Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Latin America Non-invasive Neuromodulation Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 67. Latin America Non-invasive Neuromodulation Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 68. Mexico Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Brazil Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Argentina Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Middle East & Africa Non-invasive Neuromodulation Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 72. Middle East & Africa Non-invasive Neuromodulation Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 73. Turkey Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Saudi Arabia Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. UAE Non-invasive Neuromodulation Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Non-invasive Neuromodulation Device Value Chain Figure 77. Non-invasive Neuromodulation Device Production Process Figure 78. Channels of Distribution Figure 79. Distributors Profiles Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Neuroelectrics Magstim NeuroCare Group Soterix Medical Newronika Rogue Resolutions Medtronic Philips Healthcare Shenzhen Yingchi Technology Shenzhen Hanix United Shanghai Qiankang Medical Care Company TCT Research EB Neuro SpA